CM4Cure
ActiveSummary
CM4Cure has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.8m and a net result of -€152,297. Equity is growing by about 20% per year across the filed financial years. Its solvency ranks better than 40% of 239 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
07-03
Gazette deed
NameName change · Purpose change · Power of attorney7 facts ▸
- General meeting, 27-02-2025
- Name change, CM4Cure
- Purpose change
- Other provision, “rapport du conseil d’administration justifiant la modification proposée à l’objet, dossier du Notaire soussigné” (deed in French)
- Power of attorney
- Power of attorney, Aurélie NOTTET
- Power of attorney, Roland STIERS
05-03
Gazette deed
Appointment: Colm McCarthy (CEO)Power of attorney3 facts ▸
- Board meeting, 04-02-2025
- Director appointment, Colm McCarthy (CEO)
- Power of attorney, Colm McCarthy
10-05
Gazette deed
Permanent representatives: Daniel Marechal and Isabelle Renard3 facts ▸
- Board meeting, 13-02-2024
- Permanent representative, Daniel Marechal (representative)
- Permanent representative, Isabelle Renard (representative)
About the unread acts
Of the 5 Belgian Official Gazette deeds we know for this company, 3 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.